These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 6234484

  • 1. Bromocriptine response in normoprolactinemic patients with polycystic ovary disease: a preliminary report.
    Seibel MM, Oskowitz S, Kamrava M, Taymor ML.
    Obstet Gynecol; 1984 Aug; 64(2):213-9. PubMed ID: 6234484
    [Abstract] [Full Text] [Related]

  • 2. Resistant cases of polycystic ovarian disease successfully treated with a combination of corticosteroids, clomiphene, and bromocriptine.
    Homburg R, Ashkenazi J, Goldman J.
    Int J Fertil; 1988 Aug; 33(6):393-7. PubMed ID: 2906913
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Induction of ovulation and pregnancy with HU-FSH (Metrodin) in women with polycystic ovarian disease: summary of clinical experience.
    Venturoli S, Fabbri R, Paradisi R, Magrini O, Porcu E, De Tomasi F, Flamigni C.
    Acta Eur Fertil; 1983 Aug; 14(1):29-34. PubMed ID: 6426231
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bromocriptine treatment of women with clomiphene-resistant polycystic ovary syndrome.
    Polson DW, Mason HD, Franks S.
    Clin Endocrinol (Oxf); 1987 Feb; 26(2):197-203. PubMed ID: 3117444
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of polycystic ovary disease with chronic low-dose follicle stimulating hormone: biochemical changes and ultrasound correlation.
    Seibel MM, Kamrava MM, McArdle C, Taymor ML.
    Int J Fertil; 1984 Feb; 29(1):39-43. PubMed ID: 6146583
    [Abstract] [Full Text] [Related]

  • 11. Combined therapy with bromocriptine and clomiphene citrate for patients with normoprolactinemic amenorrhea.
    Kubota T, Kamada S, Aso T.
    Int J Fertil; 1992 Feb; 37(5):277-82. PubMed ID: 1358838
    [Abstract] [Full Text] [Related]

  • 12. The effect of bromocriptine on gonadotropin and steroid secretion in polycystic ovarian disease.
    Steingold KA, Lobo RA, Judd HL, Lu JK, Chang RJ.
    J Clin Endocrinol Metab; 1986 May; 62(5):1048-51. PubMed ID: 2937800
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Value of subcutaneous and intravenous pulsatile gonadotropin releasing hormone in polycystic ovary disease.
    Saffan DS, Seibel MM.
    J Reprod Med; 1992 Jun; 37(6):545-51. PubMed ID: 1619610
    [Abstract] [Full Text] [Related]

  • 15. Prolactin levels in the polycystic ovary syndrome.
    Milewicz A.
    J Reprod Med; 1984 Mar; 29(3):193-6. PubMed ID: 6233421
    [Abstract] [Full Text] [Related]

  • 16. Selected aspects of polycystic ovarian disease.
    Goldzieher JW, Young RL.
    Endocrinol Metab Clin North Am; 1992 Mar; 21(1):141-71. PubMed ID: 1533584
    [Abstract] [Full Text] [Related]

  • 17. [Effect of bromocryptin in polycystic ovary syndrome].
    Fuhrer J, Cheviakoff S, Rubio V.
    Rev Chil Obstet Ginecol; 1989 Mar; 54(6):364-9; discussion 369-70. PubMed ID: 2485372
    [Abstract] [Full Text] [Related]

  • 18. [The ovulation-inducing effect of CB-154 on normoprolactinemic anovulatory subjects (author's transl)].
    Tamura T, Minakami H.
    Nihon Naibunpi Gakkai Zasshi; 1982 Jan 20; 58(1):49-62. PubMed ID: 6802683
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of polycystic ovary syndrome and related infertility with clomiphene resistance by compound cyproterone acetate].
    Tao Y, Dai Q, Zhang D.
    Zhonghua Fu Chan Ke Za Zhi; 1999 Sep 20; 34(9):528-32. PubMed ID: 11360636
    [Abstract] [Full Text] [Related]

  • 20. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J, Ruiz Balda JA, Romeu Sarrió A, Caballero Fernández V, Cano Trigo I, Gómez Parga JL, González Batres C, Rodríguez Escudero FJ.
    BJOG; 2003 Dec 20; 110(12):1072-7. PubMed ID: 14664878
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.